 |
Actos: Takeda, Eli Lilly told to pay $9bn damagesA US jury ordered Takeda Pharmaceutical to pay $6 billion in damages over claims that it concealed cancer risks associated with its Actos diabetes drug, the plaintiffs' lawyer said on Tuesday. The massive award was met with &q More… |
Eli Lilly opens new base in DubaiEli Lilly and Company, a leading global pharmaceutical firm, has opened its new regional headquarters for Turkey, Middle East, Africa, Russia and the CIS (TMEA-CIS) in Dubai Healthcare City. Eli Lilly will mana More… |
 |
Lilly diabetes drug as good as insulin in studyEli Lilly & Co's experimental once-weekly diabetes drug dulaglutide proved as good as insulin in controlling blood sugar in type 2 diabetics in two late-stage studies, the company said on Tuesday. More… |
 |
UAE approves new Diabetes treatmentThe UAE Ministry of Health has become the second regulatory authority in the world to register Eli Lilly's exenatide prolonged release suspension (Bydureon) treatment for type 2 diabetes. Exenatide is the first and only once weekly therapy More… |
 |
Boehringer, Eli Lilly in major diabetes drugs dealBoehringer Ingelheim and Eli Lilly and Company today announced a global agreement to jointly develop and commercialise a portfolio of diabetes compounds currently in mid- and late-stage development. Included are Boehringer Ingelheim’s two More… |
 |
Lilly osteoporosis drug regrows jaw boneEli Lilly and Co's osteoporisis drug Forteo can regrow bone in jaws damaged by severe bone-destroying conditions called osteonecrosis and periodontitis, doctors reported on Saturday. The research, reported at the annual meeting of the Amer More… |
